By Abe Sauer and David Friesen
With spending at U.S. $400 billion annually, China's healthcare market will become the world's third largest this year. And that's before the U.S. $6.3 billion China’s 12th five-Year plan committed to invest in the biopharmaceutical sector alone.
As China’s rapid development continues, one of the major challenges has been to piece together the country’s previously fragmented healthcare system. While regulatory and hospital reform are a part of this, perhaps the biggest driving force for change has been the development of the biotech and pharmaceuticals industry in the country.
Over the last 30 years, China’s growth has been fuelled in part by the rapid and dynamic development of its industrial parks (a.k.a. development zones). Significant investment in both physical and administrative development in these zones has allowed industry to flourish, bringing about success for both domestic and international companies.
Despite the well-known pressures impacting the pharmaceutical industry—shifting global markets, R&D productivity challenges and pricing and reimbursement changes —some high-performing companies are successfully navigating the patent cliff and are closing the gap between blockbuster sales loss with sales coming in from new-product launches.
Responding to a call for improved liquid medication packaging, the DoseGuard™ System provides an innovative solution for keeping kids safe from unintentional ingestion
Comar is protecting children with an easy-to-use, two part system called DoseGuard™. Responding to the call of the U.S. Centers for Disease Control and Prevention (CDC), Comar created the DoseGuard system to prevent unintentional ingestion of liquid
medications by children. The product’s innovative design gives parents and caregivers the ability to prevent infants and toddlers from gaining unsupervised access to liquid medications. Product samples are currently available.
Princeton, N.J. – Sitrof Technologies, a proven provider of IT and document management solutions for the life sciences industry, has achieved EMC Documentum D2 Certification, the company announced today.
Sitrof is among the first certified D2 integration partners capable of meeting the unique and complex ECM needs of Tier 1 life sciences firms.
ERIE, PA.--Life Science Leader, a magazine dedicated to life science executives with an editorial focus on presenting business best practices, is proud to announce that chief editor, Rob Wright, will be serving as moderator for the CPhI Worldwide Global Opportunities – Lunchtime Series, sponsored by the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) - http://www.cccmhpie.org.cn/EShowListAll.aspx Held at the Feria de Madrid, Spain on Tuesday October 9th from 11am – 2pm in rooms N107 & N108, Rob will be facilitating a discussion between the audience and speakers. Presenters include: Bin Chi, secretary general CCCMHPIE and Stefan Führing , administrator, European Commission, speaking on how to prepare for the new EU-rules for APIs. Luciano Calenti, president, ACIC Fine Chemicals, a three category 2012 Life Science Leader CMO Leadership Award winner , will be discussing how to find a manufacturing partner – a comparison between the EU and China. Charlie Jia, VP Hisoar Pharm, will explore API manufacturing and exporting trends in China http://www.cphi-lunchtimeseries.com/china/agenda/.
Yardley, PA. -- With a vision to address growing needs for proven Turnkey e-Pedigree & Serialization Solutions, Xyntek Inc., a leading global provider of Real-Time Automated IT Systems and Microprocessor Based Industrial Automation Solutions for the Life Sciences Industries, today announced a joint and mutually exclusive strategic partnership in the U.S. with Antares Vision S.r.I., a leading provider of e-pedigree and serialization technology & solutions.
Princeton, NJ - Sitrof Technologies, a premier provider of IT, consulting and technology solutions for life sciences companies, is pleased to announce the addition of Jay Rothe as Vice President of Business Development.
Rothe has more than 15 years of experience helping health care and life sciences companies effectively, efficiently and securely manage both structured and unstructured regulated content. He previously served as president of Vital Path, a GE company specializing in data and information migration and ECM solutions, and as an enterprise account manager at EMC.
Description: The 5th Workshop on the Characterization of Heparin Products will take place on August 14-15, 2012, at U.S. Pharmacopeia’s headquarters in Rockville, Md. This workshop is intended to encourage open discussion and debate on the physico-chemical and functional characterization of therapeutic products derived from heparin. Possible clinical and regulatory implications will also be a focus of the meetings. Participants will include heparin API and product manufacturers, low molecular weight heparin producers, test kit manufacturers, heparin suppliers, regulators and more. For a full meeting agenda and registration information, go to: http://uspgo.to/heparin-workshop.
Dr. Edward Chess on USP's Workshop on Heparin Products - http://www.youtube.com/watch?v=rgjZfMPmXKo
Dr. Chris Bryant on Protecting the Heparin Supply - http://uspgo.to/NotIEG
Veeva NetworkTM initiative brings together the leading multichannel marketing companies and industry consultants to improve multichannel sales and marketing effectiveness
PLEASANTON, CA & PHILADELPHIA, PA — May 15, 2012 – Veeva Systems introduced Veeva Network today to over 700 industry leaders at the Veeva Global Customer Summit, being held this week in Philadelphia, PA. Veeva Network is a cloud-based customer interaction repository (CIR) that spans all sales and marketing channels, standard data formats supported by the leading multichannel marketing companies and complete service offerings from the life sciences industry’s leading business consultants.
Want more? Visit...